These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10851536)

  • 1. Weekly 5-fluorouracil and interferon-alfa-2b in metastatic cancer.
    Quan WD; Casal R
    Cancer Biother Radiopharm; 1996 Jun; 11(3):187-91. PubMed ID: 10851536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha interferon, leucovorin, and 5-fluorouracil (ALF) in advanced cancer: results of a dose-finding study and evidence of activity in non-small cell lung cancer.
    Quan WD; Madajewicz S; Smith MR; Skeel RT
    Cancer Invest; 1994; 12(4):367-74. PubMed ID: 8032955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination therapy with 5-fluorouracil (5-FU), cisplatin (CDDP) and interferon alpha-2B (IFN alpha-2B) for advanced renal cell carcinoma].
    Fujinami K; Ikeda I; Miura T; Kondo I
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1689-91. PubMed ID: 8886046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha interferon-2b, leucovorin, and 5-fluorouracil (ALF) in non-small cell lung cancer.
    Quan WD; Casal R; Rosenfeld M; Walker PR
    Cancer Biother Radiopharm; 1996 Aug; 11(4):229-34. PubMed ID: 10851542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract.
    Wadler S; Damle S; Haynes H; Kaleya R; Schechner R; Berkenblit R; Ladner RD; Murgo A
    J Clin Oncol; 1999 Jun; 17(6):1771-8. PubMed ID: 10561214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of metastatic colorectal carcinoma with a combination of fluorouracil and recombinant interferon alfa-2b: preliminary data of a phase II study.
    Weh HJ; Platz D; Braumann D; Buggisch P; Schmiegel WH; Drescher S; Kleeberg UR; Müllerleile U; Crone-Münzebrock W; Hoffman R
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):180-4. PubMed ID: 1557644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I study of recombinant human interferon alpha-2b combined with 5-fluorouracil and cisplatin in patients with advanced cancer.
    Trudeau M; Zukiwski A; Langleben A; Boos G; Batist G
    Cancer Chemother Pharmacol; 1995; 35(6):496-500. PubMed ID: 7882458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Lenk H; Wiener N; Boese-Landgraf J; Schalhorn A
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):57-62. PubMed ID: 1553576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.
    van Herpen CM; Jansen RL; Kruit WH; Hoekman K; Groenewegen G; Osanto S; De Mulder PH
    Br J Cancer; 2000 Feb; 82(4):772-6. PubMed ID: 10732744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of stage D2 hormone refractory carcinoma of the prostate with 5-fluorouracil and Roferon-A: a Southwest Oncology Group study.
    Marshall ME; Wolf M; O'Rourke M; Barnett TC; Crawford ED
    Cancer Biother Radiopharm; 1996 Apr; 11(2):119-23. PubMed ID: 10851528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different dose regimens of 5-fluorouracil and interferon-alpha in patients with metastatic colorectal carcinoma.
    Ragnhammar P; Blomgren H; Edler D; Lundell G; Magnusson I; Sonnenfeld T
    Eur J Cancer; 1995; 31A(3):315-20. PubMed ID: 7786594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer.
    Hill M; Norman A; Cunningham D; Findlay M; Watson M; Nicolson V; Webb A; Middleton G; Ahmed F; Hickish T
    J Clin Oncol; 1995 Sep; 13(9):2317-23. PubMed ID: 7666089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I trial of fluorouracil, leucovorin, and recombinant interferon alpha-2b in patients with advanced malignancy.
    Taylor CW; Modiano MR; Woodson ME; Marcus SG; Alberts DS; Hersh EM
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):185-90. PubMed ID: 1557645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer.
    Hill M; Norman A; Cunningham D; Findlay M; Nicolson V; Hill A; Iveson A; Evans C; Joffe J; Nicolson M
    J Clin Oncol; 1995 Jun; 13(6):1297-302. PubMed ID: 7751874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
    Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
    Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience.
    Kemeny N; Younes A
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):171-5. PubMed ID: 1557642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.
    Patt YZ; Hassan MM; Lozano RD; Brown TD; Vauthey JN; Curley SA; Ellis LM
    J Clin Oncol; 2003 Feb; 21(3):421-7. PubMed ID: 12560429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of metastatic colorectal cancer patients with 5-fluorouracil in combination with recombinant subcutaneous human interleukin-2 and alpha-interferon.
    Atzpodien J; Kirchner H; Hänninen EL; Menzel T; Deckert M; Franzke A; Schomburg A; Poliwoda H
    Oncology; 1994; 51(3):273-5. PubMed ID: 8196911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of 5-fluorouracil and alpha-2b interferon in patients with hormone-refractory metastatic prostate cancer.
    Dreicer R; Forest PK; Williams RD
    Urology; 1994 Sep; 44(3):377-80. PubMed ID: 7521094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.